Harvard

Category

Disulfiram: Could this be Repurposed to Target An Over-Active Immune System Associated with the COVID-19 Cytokine Storm?

Researchers from Harvard Medical School and Boston Children’s Hospital reveal that the FDA-approved drug disulfiram, often used to treat alcoholism, blocks a key gatekeeper protein contributing to inflammation. COVID-19 kills not because of the virus itself, but...

William G. Kaelin, Jr. MD Dana-Farber Cancer Institute and 2019 Nobel Prize Winner & Live Saver

William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a rare disorder called von Hippel Lindau syndrome, triggered when one tumor-suppressor gene called VHL mutates, makes patients more likely to...

Pin It on Pinterest